Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design.Scott Thomson, Andreas Suhrbier, Barbara E.H. Coupar et al.|Proceedings of the National Academy of Sciences|1995Cited by 141
Targeting a Polyepitope Protein Incorporating Multiple Class II-Restricted Viral Epitopes to the Secretory/Endocytic Pathway Facilitates Immune Recognition by CD4<sup>+</sup>Cytotoxic T Lymphocytes: a Novel Approach to Vaccine DesignScott Thomson, Rajiv Khanna, Scott R. Burrows et al.|Journal of Virology|1998Cited by 64